Company Information

Company Biogenetics Co., Ltd
www.kyungnambiopharma.co.kr
Type:
SME
Country:
Korea, Republic of
Sector:
Medical equipment and services; Health care providers
Ownership:
Publicly Listed
Global Compact Status:
Non-Communicating
Participant Since
27 December 2010
Letter of Commitment
Next Communication on Progress (COP) due on:
05 August 2024

Financial Information


Communication On Progress

Published On Title Level/Status
17-Mar-2021 Communication on Progress Learner
19-Mar-2020 Communication on Progress Learner
19-Mar-2019 Communication on Progress Active
07-Jun-2018 Communication on Progress Learner
07-Jun-2017 Communication on Progress Active
15-Jun-2016 Communication on Progress 2016 Active
16-Dec-2014 Communication on Progress Active
12-Dec-2013 Communication on Progress Active
19-Dec-2011 Communication on Progress Active
19-Dec-2011 Communication on Progress Learner

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.